NTRB NUTRIBAND INC
-
NUTRIBAND INC Reported Earnings
Friday, September 4, 2026 · 12:00 AM ET
NUTRIBAND INC (NTRB) reported a loss of $0.07 per share on revenue of $0.44 million for the . . Revenue fell 29.70% compared to the same quarter a year ago.
Nutriband Inc. is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company is engaged in developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy. Nutriband Inc. is based in Orlando, United States.
Reported Earnings
($0.07)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
$0.44M
Revenue Estimate
—
Revenue Surprise
Revenue Growth